Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ST6GAL1 | P15907 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | POLG | P54098 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6833812 | 1.00 | ST6GAL1 (0.34) | ST6GAL1POLBPOLG | |
| SCHEMBL6835037 | 0.88 | ST6GAL1 (0.35) | ST6GAL1POLB | |
| SCHEMBL6833762 | 0.88 | ST6GAL1 (0.35) | ST6GAL1POLB | |
| SCHEMBL6834949 | 0.86 | P2RX3 (0.36) | POLB | |
| SCHEMBL6831423 | 0.86 | P2RX3 (0.36) | POLB | |
| SCHEMBL6835165 | 0.85 | ST6GAL1 (0.34) | ST6GAL1POLBPOLG | |
| SCHEMBL4350930 | 0.84 | ST6GAL1 (0.34) | ST6GAL1POLBPOLG | |
| SCHEMBL6835155 | 0.81 | TYMP (0.36) | POLB | |
| SCHEMBL6834953 | 0.81 | TYMP (0.36) | POLB | |
| SCHEMBL5200194 | 0.79 | POLB (0.37) | ST6GAL1POLBPOLG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040082774-A1 | Novel phosphate and thiophosphate protecting groups | ISIS PHARMACEUTICALS, INC. | 2004-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040082774-A1 | Novel phosphate and thiophosphate protecting groups | TYMP, MTAP, PPIP5K2 | ST6GAL1 2845/4885POLB 30/4885POLG 106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.